NWPF

News ArchivesRead News

Sleep in Parkinson's Disease With and Without Deep Brain Stimulation

Tuesday May 06, 2014

PR Newswire - New findings from The Parkinson Alliance (PA) survey entitled "Sleep in Parkinson's Disease With and Without Deep Brain Stimulation," show that sleep disturbance is highly prevalent in Parkinson's disease (PD), and deep brain stimulation therapy (DBS) may benefit sleep quality and duration. Given that sleep disturbance is a significant problem for people with PD--with health, social and psychological implications, PA conducted a survey related to sleep; 1,247 individuals with Parkinson's participated, including 353 participants who underwent DBS and 894 individuals without DBS.

The majority of participants in this study reported significant sleep disturbance. After controlling for age and disease duration, individuals who have DBS reported less night-time sleep disturbance specifically related to motor symptoms and other PD symptoms. Additionally, the individuals who had DBS reported longer duration of consecutive hours of night-time sleep as compared to the individuals who did not have DBS.

"This research conducted by The Parkinson Alliance highlights the prevalence of sleep disturbance across age and disease duration for individuals with PD. This study has a large number of participants, giving a glimpse into the pervasive nature of sleep disturbance for individuals with PD, further reinforcing the importance of assessing non-motor symptoms in this population. Importantly, this report gives an understanding about contributing factors to sleep disturbance and thorough and practical recommendations that may help improve sleep in individuals with PD," said Jeffrey Wertheimer, Ph.D., clinical neuropsychologist and Chief Research Consultant for The Parkinson Alliance. Wertheimer adds, "Sleep disturbance is often under-assessed and undertreated. Once individuals with PD and their treatment providers have a better understanding about the contributing factors to poor sleep, intervention can be initiated. Moreover, following a proper assessment of sleep disturbance, numerous techniques can be initiated, including implementation of good sleep hygiene, behavioral intervention (modifying behavior to assist with improving sleep), medications to facilitate sleep, and/or specialized sleep devices, such as CPAP (continuous positive airway pressure) or BiPAP (bilevel positive airway pressure) machines."

Baroni, Nastassia (30 April 2014). NewsFeeds. Sleep in Parkinson's Disease With and Without Deep Brain Stimulation. http://www.digitaljournal.com/pr/1898699

Recent News

Oct 18 - Fighting Parkinson's disease through dance
Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show